Anti-TNFalpha: a new dimension in the pharmacotherapy of the spondyloarthropathies !?
- PMID: 10834852
- PMCID: PMC1753169
- DOI: 10.1136/ard.59.6.404
Anti-TNFalpha: a new dimension in the pharmacotherapy of the spondyloarthropathies !?
Comment on
-
Effects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor alpha (infliximab) in spondyloarthropathy: an open pilot study.Ann Rheum Dis. 2000 Jun;59(6):428-33. doi: 10.1136/ard.59.6.428. Ann Rheum Dis. 2000. PMID: 10834859 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
